Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
Share Market News
Beaten-up ASX 200 stock jumps 14% on CEO resignation
Share Market News
Here are the top 10 ASX 200 shares today
Healthcare Shares
2 popular ASX 200 healthcare shares tanking on earnings updates
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Fallers
Why A2B, Alumina, Healius, and Nuix shares are dropping today
Share Market News
Here are the top 10 ASX 200 shares today
Share Fallers
These were the worst-performing ASX 200 shares of 2023. Should you buy them now?
Share Market News
Insiders have been buying these 5 ASX All Ords shares
Share Gainers
Why Core Lithium, Healius, Karoon Energy, and WA1 shares are racing higher
Share Market News
Meet the ASX All Ords shares that management is buying up
Share Market News
Here's how the ASX 200 market sectors stacked up this week
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.